Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of nine trials

Background— Thrombolytic therapy with intravenous alteplase within 4.5 hours of ischemic stroke onset increases the overall likelihood of an excellent outcome (no, or nondisabling, symptoms). Any improvement in functional outcome distribution has value, and herein we provide an assessment of the eff... View More